Uri Lopatin Latest Insider Activity
Management EfficiencyThe company has return on total asset (ROA) of (32.32) % which means that it has lost $32.32 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (80.11) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryAssembly Biosciences, Inc. operates as a clinical stage biotechnology company. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana. Assembly Biosciences operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 89 people.Assembly Biosciences (ASMB) is traded on BATS Exchange in USA. It is located in NEW YORK U.S.A and employs 89 people. Assembly Biosciences was previously known as ASSEMBLY BIOSCIENCES INC and was traded on BATS Exchange under the symbol VTUS. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.
Assembly Biosciences Leadership Team
Stock Performance Indicators